Predictive fActors for toleraNce to Taxane Based CHemotherapy In Older adultS Affected by mEtastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Metastatic Prostate Cancer
Related studies linked through entity extraction aliases.
Evaluation of the Technical Feasibility of Testing ct DNA for Homologous Recombination Gene Variants in Metastatic Prostate Cancer.
- Status
- COMPLETED
- Phase
- N/A
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT)
- Status
- RECRUITING
- Phase
- PHASE2
Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
The Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene Mutation
- Status
- UNKNOWN
- Phase
- PHASE2
Adjuvant High-intensity Interval Training During Chemotherapy in Metastatic Prostate Cancer Patients
- Status
- WITHDRAWN
- Phase
- NA
MENCORE-2: Audio Recordings to Improve Decision-making in Advanced Prostate Cancer
- Status
- COMPLETED
- Phase
- NA
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- Status
- RECRUITING
- Phase
- PHASE2
68Ga-PSMA PET/CT for Ra223 Assessment
- Status
- RECRUITING
- Phase
- NA
The Effect of Metformin in Patients With Metastatic Castration-resistant Prostate Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Psma Intensity Can be Altered by Androgen and Phospho-SrC Obstruction
- Status
- COMPLETED
- Phase
- PHASE2
The Effect of Metformin in Patients With Newly Diagnosed mHSPC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only
- Status
- TERMINATED
- Phase
- PHASE3
Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
177Lu-DOTA-TLX591 Safety, Biodistribution and Dosimetry Study
- Status
- COMPLETED
- Phase
- PHASE1
imPlementing ROutine Molecular Characterization in Patients With Metastatic Castration Resistant ProstaTe Cancer by NGS
- Status
- UNKNOWN
- Phase
- N/A
64Cu-TLX592 Phase I Safety, PK, Biodistribution and Dosimetry Study (CUPID Study)
- Status
- COMPLETED
- Phase
- EARLY_PHASE1